Postoperative Blood Loss Clinical Trial
Official title:
Efficacy of Modified Robert Jones Bandages on Reducing Invisible Blood Loss After Total Knee Arthroplasty: A Randomized Controlled Trial
NCT number | NCT02701946 |
Other study ID # | 785/2558 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2016 |
Est. completion date | December 2017 |
Verified date | May 2018 |
Source | Mahidol University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Total knee arthroplasty (TKA) is one of the most successful procedures in orthopaedic
surgery. Nevertheless, significant postoperative blood loss and requirement of blood
transfusion are still problematic. Total blood loss in TKA can be divided into visible and
invisible blood loss. Visible blood loss (VBL) means blood loss from the surgical field and
wound drainage while invisible blood loss (IBL) means residual blood in the knee,
extravasation into the tissues and loss due to haemolysis.
In usual practice, TKA is performed with a bloodless field using a tourniquet. Thus
intraoperative blood loss can be negligible and postoperative drainage is only considered as
VBLvisible. In terms of IBL, Sehat et al. found that TKA carried a substantial IBL. Their
results shown the mean IBL was 765 ml or 49% of the mean total blood loss after TKA.
Therefore, the true total blood loss was underestimated if not takes IBL into account.
Modified Robert Jones bandage (MRJB) is a bulky compressive dressing that often used in
orthopaedic practice. Various techniques of application have been proposed.
From the previous study, MRJB could make and maintain the anterolateral muscle compartment
pressure for at least 24 hours after TKA. Therefore, theoretically, this bandage can cause
the tamponade effect that helps to reduce tissue edema and postoperative bleeding especially
IBL after TKA. However this potential benefit of MRJB is unclear and the use of this bandage
after TKA is still controversy in clinical practice.
Status | Completed |
Enrollment | 80 |
Est. completion date | December 2017 |
Est. primary completion date | June 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients who diagnosed primary osteoarthritis of knee and scheduled for primary unilateral total knee arthroplasty - Patients aged more than 18 years Exclusion Criteria: - Patients who have a history of coagulopathy - Patients who receive antiplatelet drug in the previous week - Patients who treated other conditions with anticoagulant drug - Patients who have previous history of thromboembolic event - Patients who have vascular compromise of the operated limb - Patients who have chronic kidney disease or liver cirrhosis - Patients who refuse to participate the study - Patients who have allergy to tranexamic acid, sulfa or morphine - Patients who have blood loss per wound after surgery - Patients who can not receive spinal anesthesia and peripheral nerve block |
Country | Name | City | State |
---|---|---|---|
Thailand | Chaturong Pornrattanamaneewong | Bangkok |
Lead Sponsor | Collaborator |
---|---|
Mahidol University |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Invisible blood loss after surgery | 48 hours after surgery | ||
Primary | Time (seconds) taken to perform time up and go test | meters, turn, walk back to the chair, then sit down. | 6 weeks after surgery | |
Secondary | Postoperative visual analog pain score | 48 hours after surgery | ||
Secondary | Circumferences of thigh | 48 hours after surgery | ||
Secondary | Circumferences of knee | 48 hours after surgery | ||
Secondary | Score from Oxford knee score questionnaire | 6 weeks after surgery | ||
Secondary | Complication | 6 weeks after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05047133 -
Effect of Early Administration of TXA in Adult Hip Fractures
|
Phase 2/Phase 3 | |
Completed |
NCT02631980 -
HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?
|
Phase 3 | |
Terminated |
NCT00885924 -
Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT05889494 -
Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients
|
N/A | |
Completed |
NCT02427412 -
Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty
|
Phase 4 | |
Completed |
NCT01475669 -
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
|
Phase 3 | |
Completed |
NCT01622946 -
The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach
|
Phase 4 | |
Recruiting |
NCT05774717 -
Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis
|
Phase 1 |